Population PKS & PDS of tamsulosin, in patients with benign prostatic hyperplasia (BPH)

被引：0
|
作者：
Forrest, A
Collins, DA
Shore, RM
Rubino, CM
Yasukawa, K
Tajima, Y
Ito, Y
机构：
[1] SUNY BUFFALO,SCH PHARM,BUFFALO,NY
[2] SUNY BUFFALO,CLIN PHARMACOKINET LAB,BUFFALO,NY
[3] YAMANOUCHI USA INC,WHITE PLAINS,NY
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1996年 / 59卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：PI98 / PI98
页数：1
相关论文
共 50 条
  • [31] Superiority of Dutasteride 0.5 mg and Tamsulosin 0.2 mg for the Treatment of Benign Prostatic Hyperplasia (BPH) in Asian Subjects
    Palacios, Juan Manuel
    Masumori, Naoya
    Haque, Nazneen Mahfooz
    Sakamoto, Sadaaki
    Ye, Zhangqun
    Yoon, Sang-Jin
    Kuo, Hann-Chorng
    Brotherton, Betsy
    Wilson, Timothy
    Muganurmath, Chandra
    Mclaughlin, Megan
    Manyak, Michael
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 274 - 274
  • [32] Efficacy of combination therapy with tamsulosin and zolpidem on nocturia in patients with benign prostatic hyperplasia
    Miwa, Kousei
    Nishino, Yoshinori
    Kikuchi, Mina
    Masue, Takako
    Moriyama, Yoji
    Deguchi, Takashi
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2011, 64 (04) : 232 - 235
  • [33] Efficacy and Tolerability of Tamsulosin 0.4 mg in Patients with Symptomatic Benign Prostatic Hyperplasia
    Chung, Jae-Wook
    Choi, Seock Hwan
    Kim, Bum Soo
    Kim, Tae-Hwan
    Yoo, Eun Sang
    Kim, Chun Il
    Lee, Kyung Seop
    Kwon, Tae Gyun
    KOREAN JOURNAL OF UROLOGY, 2011, 52 (07) : 479 - 484
  • [34] Negative signalling for growth and survival in epithelial prostate cells in vivo in benign prostatic hyperplasia (BPH) after tamsulosin
    Carballido, J
    Prieto, A
    Sanz, M
    Vela-Navarrete, R
    Korstanje, C
    de Mon, MA
    JOURNAL OF UROLOGY, 2003, 169 (04): : 480 - 480
  • [35] Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia
    Lucas, MG
    Stephenson, TP
    Nargund, V
    BJU INTERNATIONAL, 2005, 95 (03) : 354 - 357
  • [36] A comparative study of terazosin and tamsulosin for symptomatic benign prostatic hyperplasia in Japanese patients
    Okada, H
    Kamidono, S
    Yoshioka, T
    Okuyama, A
    Ozono, S
    Hirao, Y
    Okajima, E
    Yamamoto, K
    Kishimoto, T
    Park, Y
    Kurita, T
    BJU INTERNATIONAL, 2000, 85 (06) : 676 - 681
  • [37] Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH)
    Sciacqua, L. V.
    Vanzulli, A.
    Di Meo, R.
    Pellegrino, G.
    Lavorato, R.
    Vitale, G.
    Carrafiello, G.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [38] Critical review of lasers in benign prostatic hyperplasia (BPH)
    Gravas, Stavros
    Bachmann, Alexander
    Reich, Oliver
    Roehrborn, Claus G.
    Gilling, Peter J.
    De La Rosette, Jean
    BJU INTERNATIONAL, 2011, 107 (07) : 1030 - 1043
  • [39] Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?
    Kramer, Gero
    Mitteregger, Dieter
    Marberger, Michael
    EUROPEAN UROLOGY, 2007, 51 (05) : 1202 - 1216
  • [40] NATURAL-HISTORY OF BENIGN PROSTATIC HYPERPLASIA (BPH)
    SCHRODER, FH
    BLOM, JHM
    PROSTATE, 1989, : 17 - 22
12345